2024
DOI: 10.1080/21645515.2024.2329446
|View full text |Cite
|
Sign up to set email alerts
|

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana

Kornchanok Sangprasat,
Christine Joy I. Bulaon,
Kaewta Rattanapisit
et al.

Abstract: Botulism is a fatal neurologic disease caused by the botulinum toxin (BoNT) produced by Clostridium botulinum . It is a rare but highly toxic disease with symptoms, such as cramps, nausea, vomiting, diarrhea, dysphagia, respiratory failure, muscle weakness, and even death. Currently, two types of antitoxin are used: equine-derived heptavalent antitoxin and human-derived immunoglobulin (BabyBIG®). However, heptavalent treatment may result in hypersensitivity, whereas BabyBIG®, has a low y… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…The produced protein by this method is sufficiently supplied throughout clinical study. This method is also employed in the production of therapeutic proteins like anti-human PD-1 antibodies [ 48 ] and anti-botulinum neurotoxins [ 49 ] which are previously developed in our laboratory. Therefore, using agroinfiltration for the production of D54 mAb is more appropriate than stable transformation.…”
Section: Discussionmentioning
confidence: 99%
“…The produced protein by this method is sufficiently supplied throughout clinical study. This method is also employed in the production of therapeutic proteins like anti-human PD-1 antibodies [ 48 ] and anti-botulinum neurotoxins [ 49 ] which are previously developed in our laboratory. Therefore, using agroinfiltration for the production of D54 mAb is more appropriate than stable transformation.…”
Section: Discussionmentioning
confidence: 99%